Indole Compounds as Selective 5-HT6 Receptor Antagonists
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for CNS disorders, obesity, diabetes, and cognitive impairments lack effective modulators for the 5-HT6 receptor, which are implicated in various physiological and pathological functions, including anxiety, depression, and memory regulation.
Innovation Solution
Development of novel indole compounds that act as selective antagonists of the 5-HT6 receptor, useful in treating a range of disorders such as obesity, diabetes, cognitive disorders, depression, and anxiety, by modulating neurotransmitter levels and improving cognitive functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for CNS disorders are used, then existing therapeutic options are available, but effective modulators for the 5-HT6 receptor are lacking
Solution Approach 1:
The patent applies parameter changes by systematically modifying chemical structures of indole compounds to optimize 5-HT6 receptor binding affinity and selectivity. By varying substituents at different positions (R1-R6) and adjusting molecular parameters, the invention creates compounds with enhanced therapeutic effectiveness for CNS disorders while maintaining selectivity for the 5-HT6 receptor subtype.
2Reliability
If novel indole compounds are developed as selective 5-HT6 antagonists, then therapeutic benefits for multiple disorders are achieved, but the complexity of compound synthesis increases
Solution Approach 1:
The patent applies segmentation by dividing the complex indole structure into modular components with defined substitution patterns. The core indole framework is maintained while allowing independent optimization of different substituent groups (R1-R6), enabling systematic synthesis through combinatorial chemistry approaches and facilitating manufacturing by breaking down the synthesis into manageable stages.
Solution Approach 2:
The patent applies universality by designing a core indole structure that provides broad therapeutic benefits across multiple disorders (CNS disorders, obesity, diabetes, cognitive impairments) while maintaining a consistent synthetic framework. This multi-functional core structure allows the same basic synthesis pathway to produce various analogs with different therapeutic profiles, reducing overall manufacturing complexity.
3Reliability
If 5-HT6 receptor antagonism is achieved, then cholinergic transmission is enhanced and cognitive functions improve, but selective antagonism requires high structural precision
Solution Approach 1:
The patent applies local quality by introducing specific substituent groups at predetermined positions on the indole ring structure to enhance 5-HT6 receptor selectivity. By optimizing local chemical environments at key positions (such as R2, R3, R4 substituents), the compounds achieve high binding affinity and selectivity for the 5-HT6 receptor while maintaining overall structural feasibility for synthesis.
Data Source
AI summary
Novel compounds of the structural formula (I) are antagonists of the 5-HT6 receptor and are useful in the treatment, prevention and suppression of diseases mediated by the 5-HT6 receptor. The compounds of the present invention are useful in the treatment of obesity, diabetes, metabolic disorder, cognitive disorders, age related cognitive disorder, depression, mania, bipolar disorders, schizophrenia, anxiety, generalized anxiety disorder, panic disorder, and obsessive compulsive disorder, epilepsy, convulsions, migraine, substance withdrawal from substances including but not limited to opiates, nicotine, tobacco products, alcohol, benzodiazepines, sedatives, and the like, sleep disorders, attention deficit/hyperactivity disorder, and Alzheimer's disease.